Cardiac Risk Assessment in Liver Transplant Candidates: Current Controversies and Future Directions.

ABSTRACT: In the changing landscape of liver transplantation (LT), we are now evaluating older and sicker patients with more cardiovascular comorbidities, and the spectrum of cardiovascular disease is uniquely physiologically impacted by end-stage liver disease. Cardiac complications are now the leading cause of morbidity and mortality in LT recipients, and the pretransplant risk is exacerbated immediately during the transplant operation and continues long term under the umbrella of immunosuppression. Accurate risk estimation of cardiac complications before LT is paramount to guide allocation of limited health care resources and to improve both short-term and long-term clinical outcomes for patients. Current screening and diagnostic testing are limited in their capacity to accurately identify early

SUBMITTER: Barman PM 

PROVIDER: S-EPMC8220582 | biostudies-literature | 2021 Jun

REPOSITORIES: biostudies-literature